Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter protein ABC1
    34.
    发明授权
    Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter protein ABC1 失效
    使用ATP结合盒转运蛋白ABC1增加胆固醇流出和提高HDL的组合物和方法

    公开(公告)号:US07351535B2

    公开(公告)日:2008-04-01

    申请号:US10920989

    申请日:2004-08-18

    摘要: The present invention relates to novel ABC1 polypeptides and nucleic acid molecules encoding the same. The invention also relates to recombinant vectors, host cells, and compositions comprising ABC1 polynucleotides, as well as to methods for producing ABC1 polypeptides. The invention also relates to antibodies that bind specifically to ABC1 polypeptides. In addition, the invention relates to methods for increasing cholesterol efflux as well as to methods for increasing ABC1 expression and activity. The present invention further relates to methods for identifying compounds that modulate the expression of ABC1 and methods for detecting the comparative level of ABC1 polypeptides and polynucleotides in a mammalian subject. The present invention also provides kits and compositions suitable for screening compounds to determine the ABC1 expression modulating activity of the compound, as well as kits and compositions suitable to determine whether a compound modulates ABC1-dependent cholesterol efflux.

    摘要翻译: 本发明涉及新型ABC1多肽和编码该ABC1多肽的核酸分子。 本发明还涉及重组载体,宿主细胞和包含ABC1多核苷酸的组合物,以及生产ABC1多肽的方法。 本发明还涉及特异性结合ABC1多肽的抗体。 此外,本发明涉及增加胆固醇流出的方法以及增加ABC1表达和活性的方法。 本发明还涉及用于鉴定调节ABC1表达的化合物的方法和用于检测哺乳动物受试者中ABC1多肽和多核苷酸的比较水平的方法。 本发明还提供适用于筛选化合物以测定化合物的ABC1表达调节活性的试剂盒和组合物,以及适合于确定化合物是否调节ABC1依赖性胆固醇流出的试剂盒和组合物。

    A1 adenosine receptor agonists
    36.
    发明授权
    A1 adenosine receptor agonists 失效
    A1腺苷受体激动剂

    公开(公告)号:US07271157B2

    公开(公告)日:2007-09-18

    申请号:US11173416

    申请日:2005-06-30

    CPC分类号: C07H19/16

    摘要: Disclosed is a synthesis suitable for large scale manufacture of novel compounds that are partial and full A1 adenosine receptor agonist having the structure of Formula I: wherein R is optionally substituted phenyl, that are useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.

    摘要翻译: 公开了适用于大规模生产具有式I结构的部分和全部A 1 N 2腺苷受体激动剂的新化合物的合成:其中R是任选取代的苯基,其可用于治疗各种疾病 状态,特别是心动过速和心房扑动,心绞痛和心肌梗死。